79867-70-2Relevant academic research and scientific papers
Design, synthesis and in vitro antitumor evaluation of novel diaryl urea derivatives bearing sulfonamide moiety
Luo, Can,Tang, Ke,Li, Yan,Yin, Dali,Chen, Xiaoguang,Huang, Haihong
, p. 1564 - 1572 (2014/01/06)
A novel series of diaryl urea derivatives bearing sulfonamide moiety have been designed and synthesized. Their in vitro antitumor effect against human cancer cell lines MX-1, A375, HepG2, Ketr3 and HT-29 was screened and evaluated by the standard MTT assa
Discovery of salermide-related sirtuin inhibitors: Binding mode studies and antiproliferative effects in cancer cells including cancer stem cells
Rotili, Dante,Tarantino, Domenico,Nebbioso, Angela,Paolini, Chantal,Huidobro, Covadonga,Lara, Ester,Mellini, Paolo,Lenoci, Alessia,Pezzi, Riccardo,Botta, Giorgia,Lahtela-Kakkonen, Maija,Poso, Antti,Steinkühler, Christian,Gallinari, Paola,De Maria, Ruggero,Fraga, Mario,Esteller, Manel,Altucci, Lucia,Mai, Antonello
, p. 10937 - 10947 (2013/02/25)
Chemical changes performed on 1a (sirtinol) led to a series of SIRT1/2 inhibitors, in some cases more potent than 1a mainly against SIRT1. Tested in human leukemia U937 cells, the benzamide and anilide derivatives 1b, 1c, 2b, and 2c as well as the 4-(2-phenylpropyl)thioanalogue 4c showed huge apoptosis induction, while some sulfinyl and sulfonyl derivatives (5b, 5c, and 6a-c) were highly efficient in granulocytic differentiation. When assayed in human leukemia MOLT4 as well as in human breast MDA-MB-231 and colon RKO cancer cell lines, the anilide 2b (salermide) and the phenylpropylthio analogue 4b emerged as the most potent antiproliferative agents. Tested on colorectal carcinoma and glioblastoma multiforme cancer stem cells (CSCs) from patients, 2b was particularly potent against colorectal carcinoma CSCs, while 4b, 6a, and the SIRT2-selective inhibitor AGK-2 showed the highest effect against glioblastoma multiforme CSCs. Such compounds will be further explored for their broad-spectrum anticancer properties.
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1
Bissinger, Elisabeth-Maria,Heinke, Ralf,Spannhoff, Astrid,Eberlin, Adrien,Metzger, Eric,Cura, Vincent,Hassenboehler, Pierre,Cavarelli, Jean,Schuele, Roland,Bedford, Mark T.,Sippl, Wolfgang,Jung, Manfred
, p. 3717 - 3731 (2011/08/03)
Arginine methylation is an epigenetic modification that receives increasing interest as it plays an important role in several diseases. This is especially true for hormone-dependent cancer, seeing that histone methylation by arginine methyltransferase I (PRMT1) is involved in the activation of sexual hormone receptors. Therefore, PRMT inhibitors are potential drugs and interesting tools for cell biology. A dapsone derivative called allantodapsone previously identified by our group served as a lead structure for inhibitor synthesis. Acylated derivatives of p-aminobenzenesulfonamides and the antilepra drug dapsone were identified as new inhibitors of PRMT1 by in vitro testing. The bis-chloroacetyl amide of dapsone selectively inhibited human PRMT1 in the low micromolar region and was selective for PRMT1 as compared to the arginine methyltransferase CARM1 and the lysine methyltransferase Set7/9. It showed anticancer activity on MCF7a and LNCaP cells and blocked androgen dependent transcription specifically in a reporter gene system. Likewise, a transcriptional block was also demonstrated in LNCaP cells using quantitative RT-PCR on the mRNA of androgen dependent genes.
Characterization of sirtuin inhibitors in nematodes expressing a muscular dystrophy protein reveals muscle cell and behavioral protection by specific sirtinol analogues
Pasco, Matthieu Y.,Rotili, Dante,Altucci, Lucia,Farina, Francesca,Rouleau, Guy A.,Mai, Antonello,Néri, Christian
supporting information; experimental part, p. 1407 - 1411 (2010/09/18)
In oculopharyngeal muscular dystrophy (OPMD), a disease caused by polyalanine expansion in the nuclear protein PABPN1, the genetic inhibition of sirtuins and treatment with sirtuin inhibitors protect from mutant PABPN1 toxicity in transgenic nematodes. He
